Literature DB >> 22825402

Asymmetry in keratoconus and vision-related quality of life.

Lisa A Jones-Jordan1, Jeffrey J Walline, Loraine T Sinnott, Steven M Kymes, Karla Zadnik.   

Abstract

PURPOSE: To examine the relationship of increased ocular asymmetry over time to vision-related quality of life in keratoconus.
METHODS: The subjects were from the Collaborative Longitudinal Evaluation of Keratoconus Study and had complete data on a least 1 scale of the National Eye Institute Visual Function Questionnaire and examination data at baseline and at least 1 follow-up visit. Three measures of disease asymmetry [visual acuity (VA), corneal curvature, and refractive error] and better eye status were assessed. Multilevel models were fit to the data.
RESULTS: The analyses were completed using the data from 961 subjects. Six scales on the National Eye Institute Visual Function Questionnaire had adequate variability to the model (distance activity, driving, mental health, near activity, ocular pain, and role difficulties). Refractive error changes were not associated with statistically significant quality-of-life differences. Except for ocular pain, statistically significant, but not clinically meaningful, differences were found for VA changes and corneal curvature changes. For a 0.1-unit logarithm of the minimum angle of resolution of VA change, the quality-of-life scales decreased between 0.20 and 0.99 units. For a 1.00-diopter steepening of corneal curvature, these decreases were on the order of 0.20 to 0.59 units. Changes related to asymmetry were small as well; decreases were on the order of 0.20 to 0.38 units.
CONCLUSIONS: Increasing ocular asymmetry and decreases in VA and corneal steepening in the better eye were associated with decreasing vision-related quality of life, although the magnitudes of the changes were not clinically meaningful. Of these 2 disease status indicators, the vision in the better eye had greater effect on the vision-related quality of life.

Entities:  

Mesh:

Year:  2013        PMID: 22825402      PMCID: PMC3482277          DOI: 10.1097/ICO.0b013e31825697c4

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  18 in total

1.  Corneal scarring and vision in keratoconus: a baseline report from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study.

Authors:  K Zadnik; J T Barr; T B Edrington; J J Nichols; B S Wilson; K Siegmund; M O Gordon
Journal:  Cornea       Date:  2000-11       Impact factor: 2.651

2.  The relation between disease asymmetry and severity in keratoconus.

Authors:  J J Nichols; K Steger-May; T B Edrington; K Zadnik
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

3.  Quality of life in keratoconus.

Authors:  Steven M Kymes; Jeffrey J Walline; Karla Zadnik; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2004-10       Impact factor: 5.258

4.  Visual acuity repeatability in keratoconus: impact on sample size. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group.

Authors:  M O Gordon; K B Schechtman; L J Davis; T T McMahon; J Schornack; K Zadnik
Journal:  Optom Vis Sci       Date:  1998-04       Impact factor: 1.973

Review 5.  Keratoconus.

Authors:  Y S Rabinowitz
Journal:  Surv Ophthalmol       Date:  1998 Jan-Feb       Impact factor: 6.048

6.  Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye study.

Authors:  Roberta McKean-Cowdin; Rohit Varma; Ron D Hays; Joanne Wu; Farzana Choudhury; Stanley P Azen
Journal:  Ophthalmology       Date:  2010-06-08       Impact factor: 12.079

7.  Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons.

Authors:  C M Mangione; S Berry; K Spritzer; N K Janz; R Klein; C Owsley; P P Lee
Journal:  Arch Ophthalmol       Date:  1998-02

Review 8.  Keratoconus and related noninflammatory corneal thinning disorders.

Authors:  J H Krachmer; R S Feder; M W Belin
Journal:  Surv Ophthalmol       Date:  1984 Jan-Feb       Impact factor: 6.048

9.  Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators.

Authors:  C M Mangione; P P Lee; J Pitts; P Gutierrez; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  1998-11

10.  Between-eye asymmetry in keratoconus.

Authors:  Karla Zadnik; Karen Steger-May; Barbara A Fink; Charlotte E Joslin; Jason J Nichols; Carol E Rosenstiel; Julie A Tyler; Julie A Yu; Thomas W Raasch; Kenneth B Schechtman
Journal:  Cornea       Date:  2002-10       Impact factor: 2.651

View more
  10 in total

1.  Replication and meta-analysis of candidate loci identified variation at RAB3GAP1 associated with keratoconus.

Authors:  Ha Ae Bae; Richard A D Mills; Richard G Lindsay; Tony Phillips; Douglas J Coster; Paul Mitchell; Jie Jin Wang; Jamie E Craig; Kathryn P Burdon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-30       Impact factor: 4.799

2.  Correlation between visual function and refractive, topographic, pachymetric and aberrometric data in eyes with keratoconus.

Authors:  Neslihan Bayraktar Bilen; Ibrahim F Hepsen; Carlos G Arce
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

3.  Single-cell atlas of keratoconus corneas revealed aberrant transcriptional signatures and implicated mechanical stretch as a trigger for keratoconus pathogenesis.

Authors:  Shengqian Dou; Qun Wang; Bin Zhang; Chao Wei; Huijin Wang; Ting Liu; Haoyun Duan; Hui Jiang; Mingna Liu; Xiaolin Qi; Qingjun Zhou; Lixin Xie; Weiyun Shi; Hua Gao
Journal:  Cell Discov       Date:  2022-07-12       Impact factor: 38.079

4.  LogMAR and Stereoacuity in Keratoconus Corrected with Spectacles and Rigid Gas-permeable Contact Lenses.

Authors:  Vinay Kumar Nilagiri; Sangeetha Metlapally; Parthasarathi Kalaiselvan; Clifton M Schor; Shrikant R Bharadwaj
Journal:  Optom Vis Sci       Date:  2018-04       Impact factor: 1.973

5.  The influence of the refractive correction on the vision-related quality of life in keratoconus patients.

Authors:  Sara Ortiz-Toquero; Sofia Perez; Guadalupe Rodriguez; Victoria de Juan; Agustin Mayo-Iscar; Raul Martin
Journal:  Qual Life Res       Date:  2015-09-03       Impact factor: 4.147

6.  Comparison of Placido disc and Scheimpflug image-derived topography-guided excimer laser surface normalization combined with higher fluence CXL: the Athens Protocol, in progressive keratoconus.

Authors:  Anastasios John Kanellopoulos; George Asimellis
Journal:  Clin Ophthalmol       Date:  2013-07-18

Review 7.  Genetic Aspects of Keratoconus: A Literature Review Exploring Potential Genetic Contributions and Possible Genetic Relationships with Comorbidities.

Authors:  Eleftherios Loukovitis; Konstantinos Sfakianakis; Panagiota Syrmakesi; Eleni Tsotridou; Myrsini Orfanidou; Dimitra Rafailia Bakaloudi; Maria Stoila; Athina Kozei; Spyridon Koronis; Zachos Zachariadis; Paris Tranos; Nikos Kozeis; Miltos Balidis; Zisis Gatzioufas; Aliki Fiska; George Anogeianakis
Journal:  Ophthalmol Ther       Date:  2018-09-06

8.  Determining the center of a keratoconus: Comparison of different tomographic parameters and impact of disease severity.

Authors:  Gernot Steinwender; Alexander Kollenc; Mehdi Shajari; Michael Sommer; Andrea Borenich; Jutta Horwath-Winter; Ewald Lindner; Nora Woltsche; Wolfgang List; Andreas Wedrich
Journal:  Front Med (Lausanne)       Date:  2022-09-20

9.  Revisiting keratoconus diagnosis and progression classification based on evaluation of corneal asymmetry indices, derived from Scheimpflug imaging in keratoconic and suspect cases.

Authors:  Anastasios John Kanellopoulos; George Asimellis
Journal:  Clin Ophthalmol       Date:  2013-07-26

10.  Demographic profile, clinical, and topographic characteristics of keratoconus patients attending at a tertiary eye center.

Authors:  Shokoofeh Rafati; Hassan Hashemi; Payam Nabovati; Asgar Doostdar; Abbasali Yekta; Mohamadreza Aghamirsalim; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2019-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.